title: Evaluation of hearing recovery in patients with sudden deafness.
abstract: It is still difficult to evaluate the efficacy of treatment of sudden deafness. Effective methods of therapy have been reported in some studies and other studies have reported spontaneous recovery. In the present study, we assessed the correlation between hearing recovery and various parameters measured during recovery. We used three parameters: hearing gain, relative hearing gain, and recovery rate. We found that the recovery rate during recovery and the parameters measured on the 7th treatment day demonstrated the greatest correlation. The recovery rate on the 7th day of treatment was found to be useful for predicting the final hearing recovery. Comparison of the recovery rate on the 7th day of treatment may be useful for the evaluation of the efficacy of treatment of sudden deafness.
authors.affiliation: Department of Otolaryngology, School of Medicine, Keio University, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Yamamoto
authors.forename: J
authors.initials: J
authors.lastname: Kanzaki
authors.forename: K
authors.initials: K
authors.lastname: Ogawa
authors.forename: S
authors.initials: S
authors.lastname: Ogawa
authors.forename: N
authors.initials: N
authors.lastname: Tsuchihashi
mesh_terms: D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000527:Alprostadil / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005544:Forecasting; D006309:Hearing / Q000502:physiology*; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy / Q000503:physiopathology; D003639:Hearing Loss, Sudden / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D011379:Prognosis; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
chemical_list: D013256:Steroids; D000255:Adenosine Triphosphate; D014568:Urokinase-Type Plasminogen Activator; D000527:Alprostadil